OBJECTIVE -Systemic oxidative stress causes insulin resistance in rodents. We tested the hypothesis that oxidative stress and insulin resistance are associated in humans.RESEARCH DESIGN AND METHODS -We used cross-sectional data from 2,002 nondiabetic subjects of the community-based Framingham Offspring Study. We measured insulin resistance with the homeostasis model and defined categorical insulin resistance as homeostasis model assessment of insulin resistance (HOMA-IR) Ͼ75th percentile. We measured oxidative stress using the ratio of urine 8-epi-prostaglandin F 2␣ (8-epi-PGF 2␣ ) to creatinine and used age-and sex-adjusted regression models to test the association of oxidative stress with insulin resistance in individuals without diabetes and among subgroups at elevated risk of diabetes.RESULTS -Across 8-epi-PGF 2␣ /creatinine tertiles, the prevalence of insulin resistance increased (18.0, 27.5, and 29.4% for the first, second, and third tertiles, respectively; P Ͻ 0.0001), as did mean levels of HOMA-IR (3.28, 3.83, and 4.06 units; P Ͻ 0.0001). The insulin resistanceoxidative stress association was attenuated by additional adjustment for BMI (P ϭ 0.06 across tertiles for insulin resistance prevalence; P ϭ 0.004 for mean HOMA-IR). Twenty-six percent of participants were obese (BMI Ն30 kg/m 2 ), 39% had metabolic syndrome (according to the Adult Treatment Panel III definition), and 37% had impaired fasting glucose (IFG) (fasting glucose 5.6 -6.9 mmol/l). Among 528 obese participants, respectively, insulin resistance prevalence was 41.3, 60.6, and 54.2% across 8-epi-PGF 2␣ /creatinine tertiles (P ϭ 0.005); among 781 subjects with metabolic syndrome, insulin resistance prevalence was 41.3, 56.7, and 51.7% (P ϭ 0.0025); and among 749 subjects with IFG, insulin resistance prevalence was 39.6, 47.2, and 51.6% (P ϭ 0.04).CONCLUSIONS -Systemic oxidative stress is associated with insulin resistance in individuals at average or elevated risk of diabetes even after accounting for BMI.